Valuation : SciBase Holding AB

Market Cap 18Cr 1.9Cr 1.64Cr 1.55Cr 1.41Cr 2.64Cr 181.98Cr 2.66Cr 7.1Cr 93Cr 7.15Cr 7Cr 292.55Cr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 18Cr 1.9Cr 1.64Cr 1.55Cr 1.41Cr 2.64Cr 181.98Cr 2.66Cr 7.1Cr 93Cr 7.15Cr 7Cr 292.55Cr EV / Sales 2026 *
3.03x
EV / Sales 2027 * 1.89x
Free-Float
35.06%
Yield 2026 *
-
Yield 2027 * -
1 day-0.82%
1 week+0.28%
Current month-6.96%
1 month-35.54%
3 months-63.90%
6 months-34.12%
Current year-47.68%
1 week 18.05
Extreme 18.05
19.2
1 month 16.85
Extreme 16.85
30
Current year 16.85
Extreme 16.85
54
1 year 16.85
Extreme 16.85
54
3 years 16.85
Extreme 16.85
129.8
5 years 16.85
Extreme 16.85
634
10 years 16.85
Extreme 16.85
2,860
Manager TitleAgeSince
Chief Executive Officer 59 01/10/2023
Director of Finance/CFO 64 01/01/2014
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 68 -
Chairman 66 13/06/2024
Director/Board Member 60 16/05/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.82%+0.28%-51.22%-80.16% 1.91Cr
+0.87%-1.81%+20.30%-31.05% 1.67TCr
-1.77%+7.05%-31.49%+58.12% 178.23Cr
+0.08%-4.28%-28.11%+22.84% 89Cr
-1.60%-14.60%-60.15%-83.99% 83Cr
-0.03%-0.19%+60.65%-3.07% 78Cr
-2.56%-5.08%-37.23%-49.60% 65Cr
-5.26%-9.30%-44.97%-48.89% 59Cr
+3.41%-14.92%-43.23%-39.69% 44Cr
+3.80%-3.68%+69.23%+49.61% 39Cr
Average -0.39%-5.91%-14.62%-20.59% 230.28Cr
Weighted average by Cap. +0.34%-4.95%+9.11%-22.86%

Financials

2026 *2027 *
Net sales 6.09Cr 62.85L 54.15L 51.28L 46.48L 87.19L 60Cr 87.63L 2.34Cr 31Cr 2.36Cr 2.31Cr 97Cr 9.77Cr 1.01Cr 86.88L 82.26L 74.56L 1.4Cr 96Cr 1.41Cr 3.76Cr 49Cr 3.79Cr 3.7Cr 154.86Cr
Net income -9.75Cr -1.01Cr -86.7L -82.09L -74.41L -1.4Cr -96Cr -1.4Cr -3.75Cr -49Cr -3.78Cr -3.7Cr -154.54Cr -6.97Cr -71.93L -61.98L -58.69L -53.19L -99.79L -69Cr -1Cr -2.68Cr -35Cr -2.7Cr -2.64Cr -110.48Cr
Net Debt - -
Logo SciBase Holding AB
SciBase Holding AB (publ) is a Sweden-based company engaged in the medical equipment industry. The Company specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma. Nevisense analyze suspicious lesions by using Electrical Impedance Spectroscopy (EIS) which is applied as an electrical signal to the skin. SciBase Holding AB (publ) specializes in early detection and prevention in dermatology. The Company develops and commercializes Nevisense, a point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management. SciBase Holding AB (publ) combines advanced EIS technology with AI to empower healthcare professionals by improving diagnostic precision, facilitating disease monitoring, and enabling early detection of skin cancer.
Employees
50
Date Price Change Volume
10/26/10 SEK 18.05 -0.82% 1,479
09/26/09 SEK 18.20 -0.55% 3,298
08/26/08 SEK 18.30 -1.08% 7,064
07/26/07 SEK 18.50 -1.86% 511
04/26/04 SEK 18.85 +4.72% 2,120

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SCIB Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!